GMAB
GENMAB SP ADR (GMAB)
NASDAQ
$25.94+$0.33 (+1.29%)
Price as of Jun 23, 2026 4:37 PM EDT
  • $15.7B
    Market Cap
  • 23.84%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
Income Statement
Total Operating Revenue
3.7B
N/A
Cost of Revenue
238.0M
N/A
Gross Profit
3.5B
N/A
Sales and Marketing Expense
626.0M
N/A
Research and Development Expense
-1.6B
N/A
Depreciation and Amortization Expense
N/A
N/A
Total Operating Expenses
626.0M
N/A
Operating Profit
1.1B
N/A
Interest Income
N/A
N/A
Interest Expense
N/A
N/A
Interest Income and Expense and Net
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
Income before Taxes
963.0M
N/A
Income Taxes
241.0M
N/A
Extraordinary Items
N/A
N/A
Net Income
963.0M
N/A
Net Income from Continuing Operations Applicable to Common
963.0M
N/A
Basic EPS and Net Income
15.50
N/A
Diluted EPS and Net Income
15.37
N/A
Basic Weighted Average Shares
64.7M
N/A
Diluted Weighted Average Shares
64.7M
N/A
Balance Sheet
Cash and Cash Equivalents
1.7B
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.7B
N/A
Total Current Assets
2.9B
N/A
Accumulated Depreciation
N/A
N/A
Property and Plant and Equipment and Net
153.0M
N/A
Total Long-Term Assets
10.0B
N/A
Total Assets
12.9B
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
1.4B
N/A
Total Long-Term Debt
N/A
N/A
Total Long-Term Liabilities
5.6B
N/A
Total Liabilities
7.0B
N/A
Retained Earnings
4.1B
N/A
Total Stockholders Equity
5.8B
N/A
Total Shares Outstanding
64.2M
N/A
Cash Flow
Cash from Operating Activities
1.2B
N/A
Capital Expenditures
N/A
N/A
Cash from Investing Activities
-5.6B
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
4.8B
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow